The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).
 
Arif Akyildiz
No Relationships to Disclose
 
Deniz Can Guven
No Relationships to Disclose
 
Baris Koksal
No Relationships to Disclose
 
Beliz Bahar Karaoğlan
No Relationships to Disclose
 
Derya Kivrak Salim
No Relationships to Disclose
 
Osman Sütcüoğlu
No Relationships to Disclose
 
Mert Erciyestepe
No Relationships to Disclose
 
Ozkan Alan
No Relationships to Disclose
 
Hakan Taban
No Relationships to Disclose
 
Nilgun Yildirim
No Relationships to Disclose
 
Teoman Sakalar
No Relationships to Disclose
 
Dogan Yazilitas
No Relationships to Disclose
 
Rashad Ismayilov
No Relationships to Disclose
 
Sercan On
No Relationships to Disclose
 
Ferit Aslan
No Relationships to Disclose
 
Nebi Serkan Demirci
No Relationships to Disclose
 
Yasemin Kemal
No Relationships to Disclose
 
Omer Diker
No Relationships to Disclose
 
Ibrahim Halil Gullu
No Relationships to Disclose
 
Sercan Aksoy
Honoraria - AstraZeneca; Bristol Myers Squibb; Lilly; Merck, Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer